These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1602848)

  • 1. A procedure for measuring neuromelanin in neurocytes by a TV-image analyser.
    Tóth V; Kummert M; Sugár J; Knoll J
    Mech Ageing Dev; 1992 Apr; 63(2):215-21. PubMed ID: 1602848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)deprenyl and (-)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin.
    Knoll J; Tóth V; Kummert M; Sugár J
    Mech Ageing Dev; 1992 Apr; 63(2):157-63. PubMed ID: 1602844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromelanic pigment in substantia nigra neurons of rats and dogs.
    DeMattei M; Levi AC; Fariello RG
    Neurosci Lett; 1986 Dec; 72(1):37-42. PubMed ID: 3492690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for specific phases in the development of human neuromelanin.
    Fedorow H; Halliday GM; Rickert CH; Gerlach M; Riederer P; Double KL
    Neurobiol Aging; 2006 Mar; 27(3):506-12. PubMed ID: 15916835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.
    Enochs WS; Nilges MJ; Swartz HM
    J Neurochem; 1993 Jul; 61(1):68-79. PubMed ID: 8390568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
    Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
    J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histochemical observations on rodent brain melanin.
    Barden H; Levine S
    Brain Res Bull; 1983 Jun; 10(6):847-51. PubMed ID: 6616275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determining aging changes of melanin granules of human scalp hairs by image analyser].
    Kita T; Hayashiba Y; Ohshima T; Minoda M; Tanaka N
    Nihon Hoigaku Zasshi; 1991 Feb; 45(1):44-51. PubMed ID: 2046173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics.
    Zecca L; Zucca FA; Wilms H; Sulzer D
    Trends Neurosci; 2003 Nov; 26(11):578-80. PubMed ID: 14585596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuromelanin in neurons of substantia nigra lacking tyrosine hydroxylase].
    Grigor'ev IP; Sukhorukova EG; Kolos EA; Korzhevskiĭ DE
    Morfologiia; 2012; 141(2):65-7. PubMed ID: 22913142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for specific phases in the development of human neuromelanin.
    Halliday GM; Fedorow H; Rickert CH; Gerlach M; Riederer P; Double KL
    J Neural Transm (Vienna); 2006 Jun; 113(6):721-8. PubMed ID: 16604299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.
    Plum S; Steinbach S; Attems J; Keers S; Riederer P; Gerlach M; May C; Marcus K
    Sci Rep; 2016 Nov; 6():37139. PubMed ID: 27841354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid content determines aggregation of neuromelanin granules in vitro.
    Dedov VN; Griffiths FM; Garner B; Halliday GM; Double KL
    J Neural Transm Suppl; 2007; (72):35-8. PubMed ID: 17982875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
    Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the function of neuromelanin and an attempt to provide a unified theory.
    Nicolaus BJ
    Med Hypotheses; 2005; 65(4):791-6. PubMed ID: 15949901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.
    Usunoff KG; Itzev DE; Ovtscharoff WA; Marani E
    Arch Physiol Biochem; 2002 Oct; 110(4):257-369. PubMed ID: 12516659
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
    Kastner A; Hirsch EC; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
    J Neurochem; 1992 Sep; 59(3):1080-9. PubMed ID: 1494900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB; Ben-Shachar D; Riederer P
    J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
    Jellinger K; Kienzl E; Rumpelmair G; Riederer P; Stachelberger H; Ben-Shachar D; Youdim MB
    J Neurochem; 1992 Sep; 59(3):1168-71. PubMed ID: 1494904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.